Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
#Healthcare #MedTech #HealthInnovation #DoctorsOfLinkedIn #HealthIT To view or add a comment, sign in Phase 3 TRANSCEND: Setmelanotide achieved a 16.5% reduction in BMI over 52 weeks by directly activating MC4R and bypassing impaired leptinPOMC signalingmarking a significant advance for patients with acquired hypothalamic obesity
30 SINGLE-SERVING TRAVEL VIALS: Say goodbye to oxidized, leaking liquid bottles that lose potency once opened
Interferon gamma (IFN-) may reverse oral submucous fibrosis
Progression of atherosclerosis with carnitine supplementation: a randomized controlled trial in the metabolic syndrome
US$ 25.28
US$ 27.34
US$ 25.20
